MedTrace Logo

LARC Forward Contraceptive Counseling at MHCC

NCT02735551 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2019-11-12

Study results available
· View outcomes & findings →

Summary

This prospective randomized controlled study will evaluate if Long Acting Reversible Contraceptive (LARC) forward counseling in combination with same-day LARC placement increases overall LARC uptake within a community college population compared to LARC forward counseling and referral to a secondary clinic for LARC placement. The study will be conducted at Mount Hood Community College (MHCC) in Oregon. Participants will be enrolled into three groups. All groups will receive the same standardized contraceptive counseling ("LARC forward counseling") and participants will be able to choose between a LARC method and short-acting method of birth control.

Conditions

  • Contraception

Interventions

DRUG

Long Acting Reversible Contraception (LARC)

Same day LARC placement (intervention) of Mirena, Skyla, Paragard, Implanon

OTHER

Referral for Long Acting Reversible Contraception (LARC)

Referral to local clinic for LARC placement of choice (Mirena, Skyla, Paragard, Implanon, etc.)

OTHER

Prescription for Short-Acting Hormonal Contraception

Participants who chose a short-acting hormonal method (e.g. contraceptive pills, ring, or patch) will receive a prescription to the pharmacy of their choice

Sponsors & Collaborators

Principal Investigators

  • Jacqueline Lamme, MD · Oregon Health and Science University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-03-13
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02735551 on ClinicalTrials.gov